SEMBIOSYS ANNOUNCES SECOND QUARTER RESULTS

SemBioSys Genetics Inc. (TSX:SBS), a biotechnology company developing a broad pipeline of protein-based pharmaceutical and non-pharmaceutical products, today announced its 2005 second quarter operational and financial results. "Our team continues to make progress, with the support of our partners, on the execution of the development and commercialization plans for our oilbody-oleosin technology based products," said Andrew Baum, President and CEO of SemBioSys Genetics Inc.

Canada NewsWire Group (http://www.newswire.ca/en/releases/archive/July2005/28/c5211.html)